← Open Payments lookup

BOBBI HULLUM: Open Payments

NPI 1861148454 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,976 in 51 payments from 13 companies in 2025. Trend: 2023 $1,863 · 2024 $3,294 · 2025 $2,976

Consulting: $1,861Food & beverage: $1,088Education: $28
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.8$2,007
Aurinia Pharma U.S., Inc.3$157
Bayer Healthcare Pharmaceuticals Inc.9$155
AstraZeneca Pharmaceuticals LP6$102
Vifor Pharma, Inc.4$89
Novartis Pharmaceuticals Corporation4$83
Otsuka America Pharmaceutical, Inc.4$82
Novo Nordisk Inc3$73
Ardelyx, Inc.3$72
Amgen Inc.3$58

Products named: TARPEYO, LUPKYNIS, Kerendia, FARXIGA, Veltassa, JYNARQUE, IBSRELA, Fabhalta.

Industry payments across PA — which companies pay providers there.